GlassScriptPhysician profile
Kris Kawamoto
NPI 1649618844
$25,443.51
in general payments reported to CMS, 2019-2025
20 companies · $5,584 in 2025
The $5,584 reported for 2025 was more than what 84% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $5,000 · 2021: $4,402 · 2022: $1,745 · 2023: $1,238 · 2024: $7,475 · 2025: $5,584.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,595 · Travel and Lodging: $6,696 · Education: $6.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,594.59 |
| Travel and Lodging | $6,696.14 |
| Education | $6.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $6,234.95 | 2024-2025 | Optis, Xience Skypoint, Dragonfly Opstar |
| Medtronic Vascular, INC. | $5,000.00 | 2020 | |
| Edwards Lifesciences Corporation | $4,264.66 | 2021-2025 | Sapien 3 Ultra Resilia |
| Abiomed | $3,690.71 | 2021-2025 | Impella |
| Philips North America LLC | $1,967.82 | 2025 | Coronary Other |
| Shockwave Medical, INC | $1,358.96 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Teleflex LLC | $735.03 | 2022-2025 | Turnpike, Guideliner, Trapliner |
| Boston Scientific Corporation | $582.45 | 2021-2025 | Avvigo Guidance System, General - Atherectomy, Stingray |
| Asahi Intecc USA, INC. | $319.12 | 2025 | Asahi Coronary Wires, Asahi Peripheral Vascular Wires |
| Cardiovascular Systems INC. | $306.16 | 2022 | |
| Medtronic, INC. | $246.51 | 2021-2025 | Resolute Onyx |
| Penumbra, INC. | $199.44 | 2022-2025 | Indigo System |
| Inari Medical, INC. | $186.22 | 2022 | |
| Biotronik INC. | $166.67 | 2023-2024 | Orsiro Mission, Pk Papyrus |
| Astrazeneca Pharmaceuticals LP | $73.55 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $43.68 | 2025 | Matrixrib |
| Terumo Medical Corporation | $22.53 | 2023 | Glidewire |
| Lemaitre Vascular, INC. | $17.60 | 2025 | Restoreflow |
| Bayer Healthcare Pharmaceuticals INC. | $16.22 | 2021 | |
| W. L. Gore & Associates, INC. | $11.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kris Kawamoto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.